The products are slated to be manufactured at the Ankleshwar facility and is expected to start contributing meaningfully to the revenue from FY25
Studies have demonstrated that ZYIL1 is highly potent and can suppress inflammation caused by NLRP3 inflammasome activation
Fischer Chemic will make an entry into the growing market of diagnostic imaging industry with innovative and disruptive technologies
This development is a strategic part of the company's commitment to bolstering its position in the advanced pharmaceutical intermediates segment
Biocon Biologics is one among the three pharmaceutical companies from India to be featured on this year's list
The company makes its maiden entry into Azerbaijan’s pharmaceutical market
Announces changes in the commercial organization to incorporate Seagen and improve focus, speed and execution
The initiation of the second clinical trial in the INTerpath program represents rapid expansion in research for additional tumor types for individualized neoantigen therapy, V940 (mRNA-4157)
The findings of Phase 3 study are in line with Phase 2 study conducted in the US and Europe
The CVMP recommends the product for approval for the treatment and persistent killing of fleas
Subscribe To Our Newsletter & Stay Updated
